Production (Stage)
Lexicon Pharmaceuticals, Inc.
LXRX
$0.7667
$0.04976.93%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -45.21% | 39.95% | 18.29% | 20.73% | 235.67% |
| Total Receivables | 3,009.24% | 243.86% | 810.38% | 282.48% | 484.67% |
| Inventory | -60.89% | -39.37% | 89.29% | 240.12% | -- |
| Prepaid Expenses | -52.65% | -11.66% | 56.28% | 25.33% | 109.35% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -32.59% | 39.45% | 20.25% | 21.66% | 232.87% |
|
|
|||||
| Total Current Assets | -32.59% | 39.45% | 20.25% | 21.66% | 232.87% |
| Net Property, Plant & Equipment | -3.43% | -2.60% | -8.63% | -15.60% | -16.53% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -55.56% | -55.56% | 11.44% | -- | -- |
| Total Assets | -28.65% | 30.07% | 16.15% | 17.88% | 156.41% |
|
|
|||||
| Total Accounts Payable | 32.50% | 2.86% | 17.99% | 16.37% | -21.76% |
| Total Accrued Expenses | -15.22% | 84.50% | 8.50% | 0.34% | 60.12% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3,238.50% | -8.99% | 0.77% | 0.00% | 0.00% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 373.07% | 43.43% | 11.73% | 6.77% | 14.86% |
|
|
|||||
| Total Current Liabilities | 373.07% | 43.43% | 11.73% | 6.77% | 14.86% |
| Long-Term Debt | -41.28% | 0.79% | 0.63% | 0.74% | 104.47% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -11.01% | -12.63% | -14.07% | -10.87% | -6.88% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 36.06% | 11.85% | 4.12% | 2.31% | 71.89% |
|
|
|||||
| Common Stock & APIC | 0.57% | 13.68% | 13.80% | 13.88% | 23.12% |
| Retained Earnings | -9.77% | -11.34% | -12.60% | -12.13% | -11.94% |
| Treasury Stock & Other | -10.65% | -57.53% | -42.29% | -61.07% | -53.05% |
| Total Common Equity | -57.41% | 56.75% | 27.96% | 28.77% | 228.06% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -57.41% | 56.75% | 27.96% | 28.77% | 228.06% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -57.41% | 56.75% | 27.96% | 28.77% | 228.09% |
|
|
|||||